BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 1474274)

  • 1. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil.
    Rodrigues ML; Silva SA; Neto JC; de Andrade AL; Martelli CM; Zicker F
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):335-9. PubMed ID: 1474274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protective efficacy of BCG against leprosy in São Paulo, Brazil].
    Lombardi C; Pedrazzani ES; Pedrazzani JC; Ferreira Filho P; Zicker F
    Bol Oficina Sanit Panam; 1995 Nov; 119(5):415-21. PubMed ID: 8540997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG vaccination protects against leprosy in Venezuela: a case-control study.
    Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of BCG against leprosy in São Paulo.
    Lombardi C; Pedrazzani ES; Pedrazzani JC; Filho PF; Zicker F
    Bull Pan Am Health Organ; 1996 Mar; 30(1):24-30. PubMed ID: 8919722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
    Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
    Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP; Ambadekar NN; Thakur A
    Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of BCG on the risk of leprosy in an endemic area: a case control study.
    Muliyil J; Nelson KE; Diamond EL
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):229-36. PubMed ID: 2071979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long lasting BCG protection against leprosy.
    Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
    Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya.
    Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of bacillus Calmette-Guerin (BCG) vaccination in the prevention of leprosy; a case-finding control study in Nagpur, India.
    Zodpey SP; Shrikhande SN; Salodkar AD; Maldhure BR; Kulkarni SW
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):309-15. PubMed ID: 9934357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between leprosy and HIV infection in Tanzania.
    van den Broek J; Chum HJ; Swai R; O'Brien RJ
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):203-10. PubMed ID: 9251592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam.
    Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India.
    Rahete NP; Zodpey SP; Kamble KM
    Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79.
    Bagshawe A; Scott GC; Russell DA; Wigley SC; Merianos A; Berry G
    Bull World Health Organ; 1989; 67(4):389-99. PubMed ID: 2680140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of BCG vaccination among leprosy contacts: a cohort study.
    Düppre NC; Camacho LA; da Cunha SS; Struchiner CJ; Sales AM; Nery JA; Sarno EN
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):631-8. PubMed ID: 18514242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution and implications of BCG scars in northern Malawi.
    Fine PE; Ponnighaus JM; Maine N
    Bull World Health Organ; 1989; 67(1):35-42. PubMed ID: 2706726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of childhood pulmonary tuberculosis: a case control study in Nagpur, India.
    Zodpey SP; Shrikhande SN; Maldhure BR; Vasudeo ND; Kulkarni SW
    Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):285-8. PubMed ID: 9886114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.